Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 2 min ago

Oncology

5,770 studies495 in 7 days2,675 in 30 days

Filters
Type
Date
Clear

Latest

5,770 studies

  1. CXCR2 knockdown reduces ERK and AKT signaling and migration in PANC-1 pancreatic cancer cells
    Jacob Krzeminski, Irene K. Guttilla Reed
    microPublication BiologyPeer-reviewedCC BYFull textOncologyDOAJ
  2. High confidence HIF-1 target genes for quantifying the activation of the HIF-1-mediated hypoxia response
    Camille AH Desnos, Aura A Tamez Gonzalez, Jeremy M Van Raamsdonk
    microPublication BiologyPeer-reviewedCC BYFull textOncologyDOAJ
  3. Redefining care for IDH-mutant low-grade gliomas: Clinical implications of the INDIGO trial and updated guidelines
    Kristin S. Bartman, Katherine B. Peters
    Clinical medicine (London, England)Peer-reviewedCC BYFull text1 citedOncologyEurope PMCPMC
  4. The current landscape of neuro-oncology clinical trials
    Neelia E. Abadi, Alissa A. Thomas, Oluwatosin O. Akintola
    Clinical medicine (London, England)Peer-reviewedCC BY-NC-NDFull text1 citedOncologyEurope PMCPMC
  5. Saffron By-Products as Underused Resources: An Ethnobotanical Survey and Phytochemical Study in the Taliouine Region
    Zineb Khadfy, Rachid Mamouni, Sm Jadouali +4
    Journal of Bioresource ManagementPeer-reviewedCC BYFull textOncologyDOAJ
  6. Cancer Screening in the Postpandemic Era: Lessons from Disruption and a Path Forward
    Gloria D. Coronado, Anna M. Morenz, Josheili Llavona-Ortiz
    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyPeer-reviewedLicence not statedFull textOncologyPMC
  7. Can restoring major histocompatibility complex class I expression overcome immune evasion in brain cancers?
    Amikishiev Sahil V., Kuzmin Dmitry A., Ovcharenko Dmitriy +1
    OncologiePeer-reviewedCC BYFull textOncologyDOAJ
  8. Radiomics of mandibular osteoradionecrosis with recurrence: the need for etiologic and temporal validation
    Erkan Topkan, Efsun Somay, Ugur Selek
    Physics and Imaging in Radiation OncologyPeer-reviewedCC BYFull textOncologyDOAJ
  9. Synthesis, Hypoxia-Selective Anti-Oral Cancer Activity and Mechanism of a CA IX-Targeting Platinum(II) Complex Based on Pyridoxal 4-Sulfamoylphenylhydrazone
    Jinxu Qi, Yanan Kou, Yunyun Zheng +2
    InorganicsPeer-reviewedCC BYFull textOncologyDOAJ
  10. Deaths Mentioning Both Pancreatic Cancer and Renal Failure in the United States, 1999–2024: Temporal Trends and Disparities
    Arkadeep Dhali, Ali Shan Hafeez, Jyotirmoy Biswas +4
    EpidemiologiaPeer-reviewedCC BYFull textOncologyDOAJ
  11. B Cells and Tumor Immunometabolism: Emerging Insights into Immune Regulation and Therapeutic Resistance
    Swati Gupta, Sandip Rath, Surathi Maiti +2
    AntibodiesPeer-reviewedCC BYFull textOncologyDOAJ
  12. FIB-4 index and adverse outcomes of coronary artery disease: a systematic review and meta-analysis
    Haoxuan Gao, Lujia Chai, Xiaolin Meng
    Postepy w kardiologii interwencyjnej = Advances in interventional cardiologyPeer-reviewedCC BY-NC-SAFull textOncologyEurope PMCPMC
  13. Breast cancer survivors’ needs for appearance care: a qualitative study
    Madoka Wakabayashi, Koji Tanaka, Kyoko Nagata +2
    Scientific ReportsPeer-reviewedCC BYFull text1 citedOncologyDOAJ
  14. Cytoplasmic SHMT2α promotes DNA damage repair and sustains cancer stemness to confer cisplatin resistance in non-small cell lung cancer: an in vitro study
    ZHANG Xinyu, GU Chen, LIU Yue +2
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  15. History, current status and prospects of proton and heavy ion radiotherapy for tumors
    JIANG Guoliang
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  16. Research advances in amino acid metabolic reprogramming in colorectal cancer liver metastasis
    WANG Ercong, YAN Junqian, JIA Xiahe +4
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  17. From "maximum tolerated intervention" to "minimum effective treatment": four decades of evolution and transformation in lung cancer surgery in Shanghai
    LI Tong, ZHANG Yang, CHEN Haiquan
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  18. Targeting the PLEKHA4-DDX3X axis reverses CDK4/6 inhibitor resistance in HR⁺/HER2⁻ breast cancer
    ZHOU Yujie, DING Youpeng, LIU Cuicui +1
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  19. A scoping review of the tiered model of palliative care delivery
    LI Shuting, CHENG Wenwu, JIANG Yan +1
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  20. Integrated multi-omics analysis reveals genomic features, MES-like states, and immune microenvironment characteristics in NF1-mutant glioblastoma
    YAO Yueying, CHEN Guoyu, LI Yanxin +1
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  21. Feasibility study of dark-field imaging for colon cancer liver metastases in mice based on a laboratory X-ray grating-based imaging system
    SHAN Ying, LU Jincheng, WU Honglin +4
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  22. Chinese Anti-Cancer Association guidelines for holistic integrative management of cancer: prostate cancer (2026 edition)
    Chinese Anti-Cancer Association Genital Oncology Committee
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  23. Integrated spatial and single-cell transcriptomics identifies TBX2 as a key transcriptional regulator in papillary thyroid carcinoma
    ZHANG Miao, WU Xiaocan, DONG Qiman +2
    Zhongguo aizheng zazhiPeer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  24. Correlation between the Prevalence of Colorectal Polyps in Patients with and without a Family History of Colorectal Cancer
    Maura Tarciany Coutinho Cajazeiras de Oliveira, Raissa Scarlet Queiroz Fernandes, Rosilma Gorete Lima Barreto +5
    Journal of ColoproctologyPeer-reviewedCC BYFull textOncologyDOAJ
  25. Functioning and disability in patients with non-small cell lung cancer
    M.S. Baklanov, Yu.V. Korota, V.S. Mokhna +3
    Medičnì PerspektiviPeer-reviewedCC BYFull textOncologyDOAJ